UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Traditional medicines for COVID‐19: Perspectives from clinical pharmacologists

British journal of clinical pharmacology, 2021-09, Vol.87 (9), p.3455-3458

2021

Volltextzugriff (PDF)

Fostering drug discovery and development in Africa

Nature medicine, 2022-08, Vol.28 (8), p.1523-1526

2022

Volltextzugriff (PDF)

Machine-Learning Assisted Screening of Correlated Covariates: Application to Clinical Data of Desipramine

The AAPS journal, 2024-05, Vol.26 (4), p.63, Article 63

2024

Volltextzugriff (PDF)

A commentary on establishing a local centre of excellence for research and training in pharmacometrics: Lessons from the pharmacometrics Africa–Uganda chapter

British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2658-2661

2023

Volltextzugriff (PDF)

Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa

British journal of clinical pharmacology, 2022-02, Vol.88 (2), p.579-586

2022

Volltextzugriff (PDF)

Clinical Pharmacology Worldwide: A Global Health Perspective

Clinical pharmacology and therapeutics, 2021-10, Vol.110 (4), p.946-951

2021

Volltextzugriff (PDF)

A Modern Curriculum for Training Scientists in Model‐Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists

Clinical pharmacology and therapeutics, 2024-08, Vol.116 (2), p.289-294

2024

Volltextzugriff (PDF)

Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries

Frontiers in pharmacology, 2022-10, Vol.13, p.1034807-1034807

2022

Volltextzugriff (PDF)

Barriers to global pharmacometrics: educational challenges and opportunities across the globe

CPT: pharmacometrics and systems pharmacology, 2023-06, Vol.12 (6), p.743-747

2023

Volltextzugriff (PDF)

Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.446-457

2012

Volltextzugriff (PDF)

Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura

Journal of clinical pharmacology, 2024-11

2024

Volltextzugriff (PDF)

Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine

Journal of antimicrobial chemotherapy, 2021-04, Vol.76 (5), p.1269-1272

2021

Volltextzugriff (PDF)

Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire

Drugs in R&D, 2024-06, Vol.24 (2), p.331-340

2024

Volltextzugriff (PDF)

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

Antimicrobial Agents and Chemotherapy, 2008-06, Vol.52 (6), p.2138-2148

2008

Volltextzugriff (PDF)

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients

European journal of clinical pharmacology, 2006-09, Vol.62 (9), p.727-735

2006

Volltextzugriff (PDF)

Pharmacokinetics /pharmacodynamics of bisphosphonates : Use for optimisation of intermittent therapy for osteoporosis

Clinical pharmacokinetics, 2005-01, Vol.44 (6), p.551-570

2005

Volltextzugriff (PDF)

Risk reduction of diarrhea and respiratory infections following a community health education program - a facility-based case-control study in rural parts of Kenya

BMC public health, 2020-04, Vol.20 (1), p.586-586, Article 586

2020

Volltextzugriff (PDF)

Open-source mobile digital platform for clinical trial data collection in low-resource settings

BMJ innovations, 2017-02, Vol.3 (1), p.26-31

2017

Volltextzugriff (PDF)

The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries

BMC medical education, 2018-10, Vol.18 (1), p.233-233, Article 233

2018

Volltextzugriff (PDF)

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.161-183

2005

Volltextzugriff (PDF)

A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis

British journal of clinical pharmacology, 2004-12, Vol.58 (6), p.618-631

2004

Volltextzugriff (PDF)

Population Pharmacokinetics of Valsartan in Pediatrics

DRUG METABOLISM AND PHARMACOKINETICS, 2009-01, Vol.24 (2), p.145-152

2009

Volltextzugriff (PDF)

Care-Seeking Dynamics among Patients with Diabetes Mellitus and Hypertension in Selected Rural Settings in Kenya

International journal of environmental research and public health, 2019-06, Vol.16 (11), p.2016

2019

Volltextzugriff (PDF)

Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment

Annual review of pharmacology and toxicology, 2022-01, Vol.62 (1), p.197-210

2022

Volltextzugriff (PDF)

Commentary on Dartois et al. – model building in population PK–PD analyses. A 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.578-579

2007

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(34)
Buchkapitel
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Traditional medicines for COVID‐19: Perspectives from clinical pharmacologists

Fostering drug discovery and development in Africa

Machine-Learning Assisted Screening of Correlated Covariates: Application to Clinical Data of Desipramine

A commentary on establishing a local centre of excellence for research and training in pharmacometrics: Lessons from the pharmacometrics Africa–Uganda chapter

Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa

Clinical Pharmacology Worldwide: A Global Health Perspective

A Modern Curriculum for Training Scientists in Model‐Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists

Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries

Barriers to global pharmacometrics: educational challenges and opportunities across the globe

Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions

Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura

Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine

Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients

Pharmacokinetics /pharmacodynamics of bisphosphonates : Use for optimisation of intermittent therapy for osteoporosis

Risk reduction of diarrhea and respiratory infections following a community health education program - a facility-based case-control study in rural parts of Kenya

Open-source mobile digital platform for clinical trial data collection in low-resource settings

The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis

Population Pharmacokinetics of Valsartan in Pediatrics

Care-Seeking Dynamics among Patients with Diabetes Mellitus and Hypertension in Selected Rural Settings in Kenya

Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment

Commentary on Dartois et al. – model building in population PK–PD analyses. A 2002–2004 literature survey

Suchergebnisse filtern